Roblox (RBLX) Gets a Buy from J.P. Morgan
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Carpenter covers the Communication Services sector, focusing on stocks such as Roblox, Roku, and Take-Two. According to TipRanks, Carpenter has an average return of -2.3% and a 38.01% success rate on recommended stocks.
In addition to J.P. Morgan, Roblox also received a Buy from Needham's Bernie McTernan in a report issued yesterday. However, on the same day, Barclays maintained a Hold rating on Roblox (NYSE: RBLX).
Based on Roblox's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $1.04 billion and a GAAP net loss of $215.06 million. In comparison, last year the company earned a revenue of $801.3 million and had a GAAP net loss of $270.6 million
Based on the recent corporate insider activity of 242 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of RBLX in relation to earlier this year. Most recently, in June 2025, David Baszucki, the President & CEO of RBLX bought 3.00 shares for a total of $301.32.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
29 minutes ago
- Business Upturn
FLR LEGAL ALERT: Lose Money on Your Fluor Corporation Investment? Contact BFA Law about its Securities Fraud Investigation (NYSE:FLR)
By GlobeNewswire Published on August 3, 2025, 16:07 IST NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Fluor Corporation (NYSE: FLR) for potential violations of the federal securities laws. If you invested in Fluor, you are encouraged to obtain additional information by visiting: Why Is Fluor being Investigated? Fluor is a global professional services firm that provides engineering, procurement and construction, fabrication and modularization, and project management services. The Company has three principal segments: Urban Solutions, Energy Solutions and Mission Solutions. Its Urban Solutions segment includes infrastructure teams that provide a broad range of services, including consulting, design, planning, financial structuring, engineering, construction and operation and maintenance services. During the relevant period, the Company touted the strong productivity across its infrastructure portfolio. In truth, several of Fluor's infrastructure projects experienced undisclosed design errors, delays, and price escalation that significantly impacted its business. The Stock Declines as the Truth Is Revealed On August 1, 2025, before market hours, Fluor reported its fiscal Q2 2025 financial results and held an earnings call. The Company announced disappointing earnings and revealed 'a $54 million net impact of cost growth and expected recoveries on three infrastructure projects, due to subcontractor design errors, the related schedule impacts, and price escalation.' The Company also announced, 'a shift in expected capital spending from some clients.' On this news, the price of Fluor stock fell more than 30% during trading on August 1, 2025. Click here for more information: What Can You Do? If you invested in Fluor you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212.789.3619 Why Bleichmar Fonti & Auld LLP? BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA , The Legal 500 , and ISS SCAS , and its attorneys have been named 'Elite Trial Lawyers' by the National Law Journal , among the top '500 Leading Plaintiff Financial Lawyers' by Lawdragon , 'Titans of the Plaintiffs' Bar' by Law360 and 'SuperLawyers' by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd. For more information about BFA and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Upturn
29 minutes ago
- Business Upturn
CNC LEGAL ALERT: Lose Money on Your Centene Corporation Investment? Contact BFA Law by September 8 Class Action Deadline (NYSE:CNC)
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Centene Corporation (NYSE: CNC) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Centene, you are encouraged to obtain additional information by visiting: Investors have until September 8, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Centene securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned: Lunstrum v. Centene Corporation, et al. , No. 25-cv-05659. Why was Centene Sued for Securities Fraud? Centene is a healthcare company that focuses on providing services to consumers enrolled in government-sponsored healthcare programs like Medicaid and Medicare, as well as those that purchase insurance under the Affordable Care Act from the Health Insurance Marketplace. On December 12, 2024, Centene announced financial guidance for fiscal year 2025 which the company said reflected '[s]tability in earnings power in the face of unprecedented headwinds.' Next, on February 4, 2025, Centene increased its 2025 guidance due to enrollment 'overperformance.' Then, on April 25, 2025, Centene again increased 2025 guidance due to continued strong growth in enrollment and retention, while touting the 'progress we are making as an organization while navigating a dynamic policy landscape.' In truth, the majority of the market that Centene serves was experiencing lower than expected enrollment growth and increased morbidity rates, or frequency of disease and illness. The Stock Declines as the Truth is Revealed On July 1, 2025, Centene abruptly withdrew its previous guidance after reviewing an independent actuarial report from Wakely Consulting Group which showed that overall market growth in 22 of the 29 states Centene serves was lower than expected and that morbidity in those states was significantly higher than expected. On this news, the price of Centene stock fell $22.87 per share, or more than 40%, from $56.65 per share on July 1, 2025 to $33.78 per share on July 2, 2025. Click here for more information: What Can You Do? If you invested in Centene you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212.789.3619
Business Upturn
30 minutes ago
- Business Upturn
BRBR LEGAL ALERT: Lose Money on Your BellRing Brands, Inc. Investment? Contact BFA Law about its Investigation (NYSE:BRBR)
By GlobeNewswire Published on August 3, 2025, 16:07 IST NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BellRing Brands, Inc. (NYSE: BRBR) for potential violations of the federal securities laws. If you invested in BellRing, you are encouraged to obtain additional information by visiting: Why is BellRing being Investigated? BellRing operates in the convenient nutrition category. The Company's primary brands include Premier Protein and Dymatize, which offer ready-to-drink protein shakes and powders. During the relevant period, the Company stated that Premier Protein 'hit an all-time high in household penetration' and that 'demand remains strong.' The Company also stated that its growth was 'strong in all channels,' driven by 'distribution expansion, accelerating velocities and incremental promotional activity.' In truth, the Company's sales growth during the relevant period may have been driven by temporary trade inventory loading at several key retailers, not sustainable end-consumer demand. The Stock Declines as the Truth is Revealed On May 5, 2025, after market hours, BellRing revealed that starting in Q2 2023, 'several key retailers lowered their weeks of supply on hand,' which would create a headwind to Q3 2025 growth. The Company also announced it was expanding promotions to boost sales and 'offset [] third quarter reductions in retailer trade inventory levels.' On this news, the price of BellRing stock fell $13.96 per share, or more than 18%, from $77.34 per share on May 5, 2025, to $63.38 per share on May 6, 2025. Click here for more information: What Can You Do? If you invested in BellRing you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212.789.3619 Why Bleichmar Fonti & Auld LLP? BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA , The Legal 500 , and ISS SCAS , and its attorneys have been named 'Elite Trial Lawyers' by the National Law Journal , among the top '500 Leading Plaintiff Financial Lawyers' by Lawdragon , 'Titans of the Plaintiffs' Bar' by Law360 and 'SuperLawyers' by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd. For more information about BFA and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
